Asian markets opened to a volatile session Friday, with Bitcoin leading a sharp crypto sell-off and stocks swinging as traders weighed President Trump's signals on a key Fed nomination and a deal to avert a government shutdown.
MGM Resorts International is powering its Las Vegas Strip operations with a major new solar and battery storage deal. This strategic shift toward renewables comes as the company's stock shows mixed signals, trading below some fair value estimates yet at a high earnings multiple, leaving investors to weigh long-term sustainability against immediate financial metrics.
Marriott International's shares have delivered impressive multi-year gains, but recent analysis suggests the hospitality giant's stock may now be trading at a significant premium. With a DCF model pointing to a 16% overvaluation and a P/E ratio exceeding industry peers, investors are debating whether the price fully reflects future growth or has outpaced fundamentals.
Amid renewed threats of steep US tariffs, South Korean officials are scrambling to salvage a key trade deal, with high-level talks in Washington failing to yield an immediate breakthrough.
Robinhood Markets is making a bold two-pronged move, expanding its tokenized stock offerings while positioning itself as a key retail gateway for SpaceX's anticipated IPO. This strategy underscores its ambition to democratize high-profile investments but also intensifies scrutiny on its regulatory risks and valuation.
Comstock Inc. (LODE) has closed a $50 million follow-on equity offering, issuing shares at $2.75. The capital infusion comes as the company's stock faces significant near-term pressure, declining over 30% in the past week, even as some analysts maintain a bullish long-term price target.
As Sempra (NYSE: SRE) navigates a massive capital investment cycle for grid modernization and clean energy, investors are scrutinizing whether its current stock price accurately reflects its long-term strategy. We analyze key valuation metrics and the broader market context to assess if the utility giant is fairly valued.
Facing the looming patent expiration of key drugs Revlimid and Eliquis, Bristol-Myers Squibb is making a strategic pivot, acquiring Orbital Therapeutics for $1.5 billion to pioneer in vivo RNA therapies. This high-stakes move aims to redefine the company's growth in oncology and autoimmune diseases.
Walmart stock jumped over 4% Monday as a new trade agreement between the U.S. and India promises lower tariffs and increased market access, bolstering the retail giant's strategic pivot toward Indian manufacturing and e-commerce.
Revvity shares have faced significant pressure, down over 13% in the past year. A deep dive into its valuation reveals a stark contradiction: while a cash flow model suggests the stock is undervalued, its price-to-earnings multiple tells a different story. We examine the numbers and what they mean for investors.
Polaris Inc. shares have surged over 55% in the past year, but a recent pullback has investors questioning whether the powersports leader remains a buy. Conflicting signals from valuation models paint a complex picture for the iconic brand.
Amid economic headwinds and geopolitical tensions, discerning investors are scouring Asian markets for hidden gems. We spotlight three companies—from China's food sector to Taiwan's tech and Japan's chemicals—trading significantly below their estimated intrinsic value, offering potential upside for the patient investor.
Shares of major cryptocurrency exchanges have plummeted as much as 60% over the past quarter, mirroring a dramatic evaporation of trading activity on their platforms. Analysts are divided on whether this signals a market bottom or the start of a more severe downturn for the digital asset sector.
As the ASX braces for a turbulent February amid rate hike fears, a closer look reveals resilient micro-caps with unique value propositions. We analyze three sub-$150M companies—from healthcare tech to critical minerals—that are navigating the volatility with strong balance sheets and niche market positions.
As investors navigate a complex economic landscape, companies with significant insider ownership and robust earnings forecasts are drawing attention. We examine three ASX-listed firms where leadership's skin in the game aligns with ambitious growth projections.
Shares of Robinhood Markets fell sharply alongside other crypto-exposed firms, pressured by a decline in Bitcoin prices and broader concerns about retail trading momentum.
As major indices climb, investors are sifting through economic crosscurrents to find resilient tech innovators. We examine three companies—Veracyte, monday.com, and Zeta Global—whose strategic moves and financial momentum position them for potential growth.
Amid a backdrop of cautious market optimism, companies with significant insider ownership are drawing investor attention. We examine three firms where those closest to the business are putting their money, spanning biotech, advanced semiconductors, and regional banking.
Via Transportation's shares have tumbled over 14% in the past month, trading near $23.25. While a discounted cash flow model suggests significant undervaluation, its price-to-sales ratio tells a more cautious story. Investors are left weighing aggressive growth projections against current market skepticism.
Shareholders in Harley-Davidson's electric motorcycle spinoff, LiveWire Group, have seen their holdings erode dramatically over five years, with a recent $55 million weekly loss adding to the pain. The company's ongoing revenue contraction raises fundamental questions about its path to profitability in the competitive EV market.
